CD7 CAR-T Combined With Autologous Hematopoietic Stem Cell Transplantation

NCT07117305 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

38

Enrollment

OTHER

Sponsor class

Conditions

CD7+ Lymphoma
T Cell Lymphoma

Interventions

DRUG: CD7 CAR-T combined with autologous hematopoietic stem cell transplantation

Sponsor

Zhengzhou University

Collaborators

[object Object]